Advertisement
In its annual report, the European Monitoring Centre for Drugs and Drug Addiction says it has detected a shift away from opiates, such as heroin, and the use of cocaine by Europeans. But it says more Europeans are using synthetic drugs, "including stimulants, new psychoactive substances and medicinal products, all of which are becoming more prominent in a changing European drug market." The growing incidence of new drugs on the market is, says the EMCDDA's Jane Mounteney, one of Europe's biggest challenges.
Jane Mounteney is the EMCDDA's head of content coordination and trend analysis.
You can read the EMCDDA's European Drug Report 2014 here.
Interview by Zulfikar Abbany